Rnc Capital Management LLC Amgen Inc Transaction History

Rnc Capital Management LLC

$1.84 Billion
Q3 2024

A detailed history of Rnc Capital Management LLC transactions in Amgen Inc stock. As of the latest transaction made, Rnc Capital Management LLC holds 3,405 shares of AMGN stock, worth $882,916. This represents 0.06% of its overall portfolio holdings.

Number of Shares

3,405

Previous 3,405 -0.0%

Holding current value

$882,916

Previous $1.06 Million 3.2%

% of portfolio

0.06%

Previous 0.06%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$262.75 - $319.31 $28,114 - $34,166	107 Added 3.24%	3,405 $1.06 Million
Q1 2024 Aug 07, 2024	SELL	$268.87 - $324.56 $983,257 - $1.19 Million	-3,657 Reduced 52.58%	3,298 $937,000
Q4 2023 Jan 17, 2024	SELL	$255.7 - $288.46 $46,537 - $52,499	-182 Reduced 2.55%	6,955 $2 Million
Q3 2023 Dec 27, 2023	SELL	$218.65 - $271.46 $44,604 - $55,377	-204 Reduced 2.78%	7,137 $1.92 Million
Q2 2023 Jul 20, 2023	SELL	$214.27 - $253.37 $64,495 - $76,264	-301 Reduced 3.94%	7,341 $1.63 Million
Q1 2023 Apr 21, 2023	SELL	$225.79 - $275.2 $5.98 Million - $7.29 Million	-26,502 Reduced 77.62%	7,642 $1.85 Million
Q4 2022 Jan 10, 2023	SELL	$229.03 - $291.01 $57,715 - $73,334	-252 Reduced 0.73%	34,144 $8.97 Million
Q3 2022 Oct 18, 2022	SELL	$224.46 - $253.15 $1.7 Million - $1.91 Million	-7,561 Reduced 18.02%	34,396 $7.75 Million
Q2 2022 Jul 22, 2022	BUY	$230.71 - $256.74 $7.33 Million - $8.16 Million	31,789 Added 312.64%	41,957 $10.2 Million
Q1 2022 Jul 22, 2022	SELL	$219.27 - $242.57 $354,559 - $392,235	-1,617 Reduced 13.72%	10,168 $2.46 Million
Q4 2021 Feb 04, 2022	SELL	$198.88 - $227.6 $28,240 - $32,319	-142 Reduced 1.19%	11,785 $2.65 Million
Q3 2021 Nov 02, 2021	SELL	$212.27 - $248.7 $39,906 - $46,755	-188 Reduced 1.55%	11,927 $2.54 Million
Q2 2021 Jul 20, 2021	SELL	$233.58 - $259.14 $14,949 - $16,584	-64 Reduced 0.53%	12,115 $2.95 Million
Q1 2021 Apr 26, 2021	SELL	$221.91 - $258.6 $1.26 Million - $1.46 Million	-5,660 Reduced 31.73%	12,179 $3.03 Million
Q4 2020 Jan 13, 2021	SELL	$216.38 - $257.67 $27.8 Million - $33.1 Million	-128,461 Reduced 87.81%	17,839 $4.1 Million
Q3 2020 Dec 03, 2020	SELL	$234.65 - $260.95 $527,023 - $586,093	-2,246 Reduced 1.51%	146,300 $37.2 Million
Q2 2020 Jul 23, 2020	SELL	$197.81 - $242.74 $6.08 Million - $7.46 Million	-30,719 Reduced 17.14%	148,546 $35 Million
Q1 2020 Apr 22, 2020	SELL	$182.24 - $241.7 $87,839 - $116,499	-482 Reduced 0.27%	179,265 $36.3 Million
Q4 2019 Mar 09, 2020	BUY	$189.21 - $243.2 $791,087 - $1.02 Million	4,181 Added 2.38%	179,747 $43.3 Million
Q3 2019 Jul 22, 2020	SELL	$174.11 - $208.62 $1.39 Million - $1.67 Million	-7,993 Reduced 4.35%	175,566 $34 Million
Q2 2019 Jul 25, 2019	SELL	$166.7 - $195.41 $142,195 - $166,684	-853 Reduced 0.46%	183,559 $33.8 Million
Q1 2019 Apr 18, 2019	SELL	$180.87 - $203.88 $553,643 - $624,076	-3,061 Reduced 1.63%	184,412 $35 Million
Q4 2018 Jan 15, 2019	BUY	$178.4 - $208.25 $208,728 - $243,652	1,170 Added 0.63%	187,473 $36.5 Million
Q3 2018 Oct 25, 2018	BUY	$185.29 - $208.89 $363,909 - $410,259	1,964 Added 1.07%	186,303 $38.6 Million
Q2 2018 Jul 20, 2018	BUY	$166.05 - $186.51 $855,323 - $960,713	5,151 Added 2.87%	184,339 $34 Million
Q1 2018 Apr 11, 2018	BUY	$169.43 - $198.0 $603,848 - $705,672	3,564 Added 2.03%	179,188 $30.5 Million
Q4 2017 Jan 17, 2018	BUY	$168.79 - $188.59 $263,312 - $294,200	1,560 Added 0.9%	175,624 $30.5 Million
Q3 2017 Oct 16, 2017	BUY	$167.29 - $191.0 $5.77 Million - $6.59 Million	34,496 Added 24.72%	174,064 $32.5 Million
Q2 2017 Aug 22, 2017	BUY	N/A	139,568	139,568 $24 Million

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $139B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rnc Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rnc Capital Management LLC with notifications on news.

Account

Rnc Capital Management LLC Amgen Inc Transaction History